Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Ahmed Kandeil and Mahmoud Shehata.
Connection Strength

1.959
  1. Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2. PLoS One. 2020; 15(10):e0241471.
    View in: PubMed
    Score: 0.228
  2. Coding-Complete Genome Sequences of Two SARS-CoV-2 Isolates from Egypt. Microbiol Resour Announc. 2020 May 28; 9(22).
    View in: PubMed
    Score: 0.221
  3. A Recombinant Influenza A/H1N1 Carrying A Short Immunogenic Peptide of MERS-CoV as Bivalent Vaccine in BALB/c Mice. Pathogens. 2019 Dec 02; 8(4).
    View in: PubMed
    Score: 0.214
  4. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East. Viruses. 2019 08 05; 11(8).
    View in: PubMed
    Score: 0.209
  5. Bacterial Outer Membrane Vesicles (OMVs)-based Dual Vaccine for Influenza A H1N1 Virus and MERS-CoV. Vaccines (Basel). 2019 05 28; 7(2).
    View in: PubMed
    Score: 0.206
  6. Middle East respiratory syndrome coronavirus infection in non-camelid domestic mammals. Emerg Microbes Infect. 2019; 8(1):103-108.
    View in: PubMed
    Score: 0.201
  7. Complete Genome Sequence of Middle East Respiratory Syndrome Coronavirus Isolated from a Dromedary Camel in Egypt. Genome Announc. 2016 Apr 28; 4(2).
    View in: PubMed
    Score: 0.167
  8. Surveillance for Coronaviruses in Bats, Lebanon and Egypt, 2013-2015. Emerg Infect Dis. 2016 Jan; 22(1):148-50.
    View in: PubMed
    Score: 0.163
  9. Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort. PLoS Pathog. 2021 03; 17(3):e1009413.
    View in: PubMed
    Score: 0.058
  10. FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2. Pharmaceuticals (Basel). 2020 Dec 04; 13(12).
    View in: PubMed
    Score: 0.057
  11. Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Antibodies in Egyptian Convalescent Plasma Donors. Front Microbiol. 2020; 11:596851.
    View in: PubMed
    Score: 0.057
  12. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science. Microorganisms. 2020 Jul 02; 8(7).
    View in: PubMed
    Score: 0.056
  13. Cross-sectional surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels and other mammals in Egypt, August 2015 to January 2016. Euro Surveill. 2017 Mar 16; 22(11).
    View in: PubMed
    Score: 0.044
  14. Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt. Emerg Microbes Infect. 2017 Jan 04; 6(1):e1.
    View in: PubMed
    Score: 0.044
  15. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. 2013 Sep 05; 18(36):pii=20574.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.